PureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders – Medical Marijuana Program Connection

[ad_1]

BOSTON–(BUSINESS WIRE)–PureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders Source link … Read More

[ad_2]